SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,397 JPY | -0.23% |
|
+0.31% | +8.81% |
Presenter SpeechIsao Teshirogi (Executives)Hello, I am Teshirogi. Thank you very much for comi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,397
JPY
Average target price
7,782
JPY
Spread / Average Target
+5.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.81% | 13.61B | |
| +32.95% | 700B | |
| -4.97% | 358B | |
| +18.83% | 330B | |
| +3.54% | 287B | |
| +15.70% | 236B | |
| +6.68% | 202B | |
| -9.08% | 197B | |
| +6.70% | 161B | |
| -1.81% | 157B |
- Stock Market
- Equities
- 4507 Stock
- News Shionogi & Co., Ltd.
- Transcript : Shionogi & Co., Ltd. - Special Call